Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-021-01080-z ◽

2021 ◽

Author(s):

Sabine E. Grimm ◽

Ben Wijnen ◽

Rob Riemsma ◽

Debra Fayter ◽

Nigel Armstrong ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Evidence Review Group ◽

Technology Appraisal ◽

Severe Rheumatoid Arthritis ◽

Single Technology Appraisal ◽

Review Group ◽

Evidence Review

Download Full-text

Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0677-7 ◽

2018 ◽

Vol 36 (12) ◽

pp. 1427-1437 ◽

Author(s):

Iñigo Bermejo ◽

Shijie Ren ◽

Emma Simpson ◽

Mark Clowes ◽

David L. Scott ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Evidence Review Group ◽

Technology Appraisal ◽

Severe Rheumatoid Arthritis ◽

Single Technology Appraisal ◽

Review Group ◽

Previously Treated ◽

Evidence Review

Download Full-text

Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0616-7 ◽

2018 ◽

Vol 36 (7) ◽

pp. 769-778 ◽

Author(s):

Shijie Ren ◽

Iñigo Bermejo ◽

Emma Simpson ◽

Ruth Wong ◽

David L. Scott ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Evidence Review Group ◽

Technology Appraisal ◽

Severe Rheumatoid Arthritis ◽

Single Technology Appraisal ◽

Review Group ◽

Previously Treated ◽

Evidence Review

Download Full-text

Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-017-0521-5 ◽

2017 ◽

Vol 35 (11) ◽

pp. 1141-1151 ◽

Author(s):

Iñigo Bermejo ◽

Matt Stevenson ◽

Rachel Archer ◽

John W. Stevens ◽

Edward Goka ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Certolizumab Pegol ◽

Evidence Review Group ◽

Inadequate Response ◽

Technology Appraisal ◽

Single Technology Appraisal ◽

Review Group ◽

Tnf Α ◽

Evidence Review

Download Full-text

Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0639-0 ◽

2018 ◽

Vol 36 (9) ◽

pp. 1063-1072 ◽

Author(s):

Lesley Uttley ◽

Iñigo Bermejo ◽

Shijie Ren ◽

Marrissa Martyn-St James ◽

Ruth Wong ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Evidence Review Group ◽

Technology Appraisal ◽

Single Technology Appraisal ◽

Review Group ◽

Evidence Review ◽

Disease Modifying

Download Full-text

Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0436-6 ◽

2016 ◽

Vol 34 (12) ◽

pp. 1241-1253 ◽

Author(s):

Rachid Rafia ◽

Alison Scope ◽

Sue Harnan ◽

John W. Stevens ◽

Matt Stevenson ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Evidence Review Group ◽

Technology Appraisal ◽

Single Technology Appraisal ◽

Review Group ◽

Prior Therapy ◽

Evidence Review

Download Full-text

Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective

PharmacoEconomics ◽

10.1007/s40273-015-0296-5 ◽

2015 ◽

Vol 33 (11) ◽

pp. 1187-1194 ◽

Author(s):

Emma L. Simpson ◽

Sarah Davis ◽

Praveen Thokala ◽

Penny R. Breeze ◽

Peter Bryden ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Technology Appraisal ◽

Single Technology Appraisal ◽

Review Group ◽

Evidence Review

Download Full-text

Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0725-3 ◽

2018 ◽

Vol 37 (6) ◽

pp. 753-762

Author(s):

Joanna Picot ◽

Neelam Kalita ◽

Wendy Gaisford ◽

Petra Harris ◽

Oluchukwu Onyimadu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Evidence Review Group ◽

Technology Appraisal ◽

Single Technology Appraisal ◽

Review Group ◽

Hormone Receptor Positive ◽

Evidence Review

Download Full-text

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0738-y ◽

2018 ◽

Vol 37 (7) ◽

pp. 887-894 ◽

Author(s):

Bram L. T. Ramaekers ◽

Rob Riemsma ◽

Sabine Grimm ◽

Debra Fayter ◽

Sohan Deshpande ◽

...

Keyword(s):

Arsenic Trioxide ◽

Acute Promyelocytic Leukaemia ◽

Evidence Review Group ◽

Promyelocytic Leukaemia ◽

Technology Appraisal ◽

Single Technology Appraisal ◽

Review Group ◽

Evidence Review

Download Full-text

Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0743-1 ◽

2018 ◽

Vol 37 (5) ◽

pp. 739-739

Author(s):

Lindsay Claxton ◽

Joanne O’Connor ◽

Nerys Woolacott ◽

Kath Wright ◽

Robert Hodgson

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Evidence Review Group ◽

Technology Appraisal ◽

Small Cell Lung ◽

Single Technology Appraisal ◽

Review Group ◽

Anaplastic Lymphoma ◽

Group Evaluation ◽

Evidence Review

Download Full-text

Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-021-01098-3 ◽

2021 ◽

Author(s):

Sabine E. Grimm ◽

Willem Witlox ◽

Robert Wolff ◽

Annette Chalker ◽

Mickael Hiligsmann ◽

...

Keyword(s):

Mycosis Fungoides ◽

Evidence Review Group ◽

Sézary Syndrome ◽

Sezary Syndrome ◽

Technology Appraisal ◽

Single Technology Appraisal ◽

Review Group ◽

Previously Treated ◽

Evidence Review

Download Full-text